Barclays’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Sell |
50,394
-30,996
| -38% | -$94.7K | ﹤0.01% | 3654 |
|
|
2025
Q1 | $157K | Sell |
81,390
-8,196
| -9% | -$15.8K | ﹤0.01% | 3461 |
|
|
2024
Q4 | $336K | Buy |
89,586
+19,419
| +28% | +$72.8K | ﹤0.01% | 3270 |
|
|
2024
Q3 | $343K | Buy |
70,167
+12,418
| +22% | +$60.7K | ﹤0.01% | 3205 |
|
|
2024
Q2 | $433K | Buy |
57,749
+14,655
| +34% | +$110K | ﹤0.01% | 2613 |
|
|
2024
Q1 | $1.07M | Buy |
+43,094
| New | +$1.07M | ﹤0.01% | 2360 |
|